医学分子生物学杂志 ›› 2024, Vol. 21 ›› Issue (1): 77-80.doi: 10.3870/j.issn.1672-8009.2024.01.012

• 综述 • 上一篇    下一篇

抗白念珠菌新型化合物及靶点的研究进展 #br#

  

  1. 山西医科大学第二医院皮肤性病科 太原市, 030001

  • 出版日期:2024-01-31 发布日期:2024-03-07

Advances in Novel Compounds and Targets Against Candida albicans #br#

  1. Department of Dermatology and Venereal Disease, the Second Hospital of Shanxi Medical University, Taiyuan, 030001, China

  • Online:2024-01-31 Published:2024-03-07

摘要: 近年来真菌感染肆虐全球每年感染约数十亿人其中死亡人数近 150 万人严重威胁着人类的生命安全。 白念珠菌是真菌感染中最主要的的病原体之一它引起的侵袭性念珠菌病死亡率高达 40 % ~ 50 % ,但是由于抗真菌药物的种类有限并且耐药现象越来越严重使得白念珠菌的临床治疗尤为棘手。 因此寻找新型抗真菌化合物根据抗真菌的独特的分子靶标开发靶向药物尤为重要。 文章综述了近几年一些具有较大潜力的新型抗白念珠菌化合物以及一些新型抗真菌靶点

关键词: 白念珠菌,  , 耐药,  , 线粒体,  , 生物膜,  , 药物靶点

Abstract: In recent years, fungal infections have been rampant worldwide, affecting approximately hundreds of millions of people annually, with nearly 1. 5 million deaths, posing a significantthreat to human health. Candida albicans is one of the most important pathogens responsible for fungal infections, and it causes invasive candidiasis with a mortality rate of 40 % -50 % . However, the limited variety of available antifungal drugs and the increasing severity of drug resistance make theclinical treatment of Candida albicans particularly challenging. Therefore, it is particularly importantto search for new antifungal compounds and unique molecular targets for antifungal therapy. This review summarizes some novel antifungal compounds with significant potential against Candida albicansand some new antifungal targets in recent years.

Key words: Candida albicans, drug resistance, mitochondria, biofilm, drug targets

中图分类号: